07:33 EDT Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on REGN:
- Decibel Therapeutics (NASDAQ:DBTX) Skyrockets On Acquisition By Regeneron
- Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Regeneron price target raised to $950 from $900 at Oppenheimer
- Regeneron Reports Second Quarter 2023 Financial and Operating Results